Advising Apera Asset Management on the financing of Essling Capital’s acquisition of Teknimed
De Pardieu Brocas Maffei has advised Apera Asset Management, a pan-European private debt investor in the midmarket space, on the debt financing for the acquisition by Essling Expansion, Essling Capital’s growth fund, a majority share in the capital of Teknimed Group.
Group’s majority shareholder, Essling Expansion, alongside with Multicroissance and Groupe Bourrelier, takes over from the previous trio of investors formed by Apax Partners, Bpifrance and Crédit-Mutuel Equity.
Based in Toulouse, Teknimed is a leading player in the implantable biomaterials market, particularly in the development and manufacturing of bone cements in France for 30 years.
Thanks to these assets, Teknimed intends to boost its organic growth, which has so far been around 10% per year, by maintaining innovation at the heart of its project and by accelerating in some geographies, such as North America, including through OEM contracts. To quicken this new development phase, the shareholders will focus on implementing an ambitious Buy & Build strategy that will also enable the integration of disruptive or complementary technologies.Link to the article Download the PDF